Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, double-blind, placebo-controlled phase I/II prevention trial (parallel assignment) evaluating STMC-103H in newborns and infants with history of asthma, atopic dermatitis, food allergy, or allergic rhinitis.
Primary outcome measures:
Safety, efficacy (incidence of physician-diagnosed atopic dermatitis at 336 days)
see also:
STMC-103H
…